Medicine and Dentistry
Patient
74%
Chemotherapeutic Agent
67%
Drug
67%
Amoxicillin
56%
Clavulanic Acid
51%
Macrolide
46%
Liver Injury
43%
Granulocyte Colony Stimulating Factor
40%
Agranulocytosis
40%
Acute Kidney Injury
40%
Toxic Hepatitis
40%
Meta-Analysis
33%
Systematic Review
33%
Tiotropium Bromide
33%
Association
31%
Inpatient
27%
Respimat
26%
Diagnosis
25%
Incidence
23%
Age
20%
Antibiotics
17%
Hospital
14%
Combination Therapy
14%
Person
13%
Case Fatality Rate
13%
Study Design
13%
Case Report
13%
Prevalence
13%
Life
13%
Risk Evaluation
10%
Adverse Event
9%
Health
9%
Infection
8%
Respiratory Tract Infection
8%
Streptogramin
8%
Hazard Ratio
6%
Proportional Hazards Model
6%
Population Research
6%
Therapeutic Procedure
6%
Prognostic Factor
6%
Neutrophil
6%
Cost-Effectiveness Analysis
6%
Checklist
6%
Physician
6%
Chronic Obstructive Pulmonary Disease
6%
Gender
6%
Antiinfective Agent
6%
Patient Characteristics
6%
Parasympatholytic
6%
ICD-10
5%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
100%
Incidence
63%
Amoxicillin
56%
Clavulanic Acid
51%
Macrolide
46%
Liver Injury
43%
Granulocyte Colony Stimulating Factor
40%
Agranulocytosis
40%
Acute Kidney Failure
40%
Toxic Hepatitis
40%
Direct Oral Anticoagulant
32%
Chemotherapy
26%
Study Design
24%
Anticoagulant Agent
24%
Adverse Drug Reaction
24%
Drug Utilization
22%
Antibiotic Agent
17%
Adverse Event
17%
Observational Study
16%
Rivaroxaban
16%
Comorbidity
16%
Dabigatran
16%
Apixaban
16%
Atrial Fibrillation
16%
Case Fatality Rate
13%
Randomized Clinical Trial
13%
Placebo
13%
Prevalence
13%
Mortality
11%
Defined Daily Dose
8%
Randomized Controlled Trial
8%
Streptogramin Derivative
8%
Respiratory Tract Infection
8%
Infection
8%
Antiinfective Agent
6%
Cholinergic Receptor Blocking Agent
6%
Chronic Obstructive Lung Disease
6%
ICD-10
5%
Isoniazid Plus Pyrazinamide Plus Rifampicin
5%
Captopril
5%
Furosemide
5%
Hydrochlorothiazide
5%
Acetylsalicylic Acid
5%
Metoclopramide
5%
Liver Disease
5%
Chlorpromazine
5%
Etiology
5%
Diazepam
5%
Alprazolam
5%
Ticlopidine
5%
